BACKGROUND: The stable or second wave of platelet aggregation often observed in ADP-stimulated platelet-rich plasma (PRP) with an artificially lowered extracellular calcium level has been attributed to enhanced thromboxane A2 (TXA2 ) generation and inhibition of ectonucleotidase activity. However, the role of thrombin in ADP-induced platelet secretion and the second wave of aggregation is unknown. OBJECTIVES AND METHODS: We employed aggregometry, flow cytometry, immunoblotting and ELISA to determine whether and how thrombin participates in ADP-induced platelet secretion and the second wave of aggregation. RESULTS: ADP induces a phosphoinositide 3-kinase (PI3K) pathway-dependent thrombin generation, presumably resulting from the cleavage of αII b β3 -associated prothrombin. Generated thrombin subsequently activates protease-activated receptor-1 (PAR-1) and mediates dense granule secretion and the second wave of platelet aggregation in ADP-stimulated citrated PRP. Thus, ADP-induced dense granule secretion and the second wave of platelet aggregation in PRP were similarly and non-additively blocked by thrombin inhibitor hirudin, PAR-1 antagonist SCH-79797 or PI3K inhibitor wortmannin. Moreover, ADP stimulation caused the dissociation of prothrombin from αII b β3 and an increased plasma thrombin level; both were prevented by wortmannin. Furthermore, the wortmannin-inhibited second wave of platelet aggregation by ADP was restored by a subaggregation concentration of PAR-1 activating peptide SFLLRN. Blocking TXA2 production with indomethacin or restoring extracellular calcium to physiological concentration did not influence this thrombin/PAR-1 dependence. CONCLUSIONS: A PI3K-dependent thrombin generation and the resultant PAR-1 activation serve as an indispensable mechanism to relay the platelet activation process induced by ADP.
BACKGROUND: The stable or second wave of platelet aggregation often observed in ADP-stimulated platelet-rich plasma (PRP) with an artificially lowered extracellular calcium level has been attributed to enhanced thromboxane A2 (TXA2 ) generation and inhibition of ectonucleotidase activity. However, the role of thrombin in ADP-induced platelet secretion and the second wave of aggregation is unknown. OBJECTIVES AND METHODS: We employed aggregometry, flow cytometry, immunoblotting and ELISA to determine whether and how thrombin participates in ADP-induced platelet secretion and the second wave of aggregation. RESULTS:ADP induces a phosphoinositide 3-kinase (PI3K) pathway-dependent thrombin generation, presumably resulting from the cleavage of αII b β3 -associated prothrombin. Generated thrombin subsequently activates protease-activated receptor-1 (PAR-1) and mediates dense granule secretion and the second wave of platelet aggregation in ADP-stimulated citrated PRP. Thus, ADP-induced dense granule secretion and the second wave of platelet aggregation in PRP were similarly and non-additively blocked by thrombin inhibitor hirudin, PAR-1 antagonist SCH-79797 or PI3K inhibitor wortmannin. Moreover, ADP stimulation caused the dissociation of prothrombin from αII b β3 and an increased plasma thrombin level; both were prevented by wortmannin. Furthermore, the wortmannin-inhibited second wave of platelet aggregation by ADP was restored by a subaggregation concentration of PAR-1 activating peptide SFLLRN. Blocking TXA2 production with indomethacin or restoring extracellular calcium to physiological concentration did not influence this thrombin/PAR-1 dependence. CONCLUSIONS: A PI3K-dependent thrombin generation and the resultant PAR-1 activation serve as an indispensable mechanism to relay the platelet activation process induced by ADP.
Authors: Tatiana F Ottaiano; Sheila S Andrade; Cleide de Oliveira; Mariana C C Silva; Marcus V Buri; Maria A Juliano; Manoel J B C Girão; Misako U Sampaio; Alvin H Schmaier; Alexander Wlodawer; Francisco H A Maffei; Maria Luiza V Oliva Journal: Biochimie Date: 2017-01-20 Impact factor: 4.079
Authors: Vanessa M Scanlon; Alexandra M Teixeira; Tarun Tyagi; Siying Zou; Ping-Xia Zhang; Carmen Jane Booth; M Anna Kowalska; Jialing Bao; John Hwa; Vincent Hayes; Michael S Marks; Mortimer Poncz; Diane S Krause Journal: Thromb Haemost Date: 2019-03-12 Impact factor: 5.249
Authors: Elisabeth M Battinelli; Beth A Markens; Rajesh A Kulenthirarajan; Kellie R Machlus; Robert Flaumenhaft; Joseph E Italiano Journal: Blood Date: 2013-09-24 Impact factor: 22.113
Authors: Amin Polzin; Lisa Dannenberg; René M'Pembele; Philipp Mourikis; David Naguib; Saif Zako; Carolin Helten; Tobias Petzold; Bodo Levkau; Thomas Hohlfeld; Mareike Barth; Tobias Zeus; Stephan Sixt; Ragnar Huhn; Payam Akhyari; Artur Lichtenberg; Malte Kelm; Till Hoffmann Journal: Sci Rep Date: 2022-07-28 Impact factor: 4.996